Aman M G, Werry J S, Paxton J W, Turbott S H, Stewart A W
Nisonger Center for Mental Retardation and Developmental Disabilities, Ohio State University, Columbus 43210-1205.
Epilepsia. 1990 Jan-Feb;31(1):51-60. doi: 10.1111/j.1528-1157.1990.tb05360.x.
Fifty children with well-controlled seizures who were receiving carbamazepine (CBZ) monotherapy were tested on a battery of cognitive and motor tests. Time of CBZ was varied so that the children were tested both shortly after CBZ (when daily CBZ concentrations approached their peak) and before CBZ (when CBZ concentrations approached daily low or trough levels). Testing was blind so that the examiner was unaware of the time of CBZ or the child's type of seizure. Results showed only one group difference related to seizure type and no differences linked to overall CBZ concentration as measured in saliva. Peak and trough concentrations were associated with changes in several variables, however. The children performed significantly better shortly after CBZ (peak concentration day) on measures of seat activity, attention span, and motor steadiness, whereas response times appeared to be influenced in a task-specific manner.
对50名接受卡马西平(CBZ)单一疗法且癫痫发作得到良好控制的儿童进行了一系列认知和运动测试。改变服用CBZ的时间,以便在服用CBZ后不久(当每日CBZ浓度接近峰值时)和服用CBZ前(当CBZ浓度接近每日低水平或谷值时)对儿童进行测试。测试是盲法进行的,因此检查人员不知道服用CBZ的时间或儿童的癫痫发作类型。结果显示,仅存在一组与癫痫发作类型相关的差异,且与唾液中测得的总体CBZ浓度无关。然而,峰值和谷值浓度与几个变量的变化有关。在座位活动、注意力持续时间和运动稳定性测量方面,儿童在服用CBZ后不久(峰值浓度日)表现明显更好,而反应时间似乎受到特定任务方式的影响。